ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

New Chemotherapy, Other Modality Progress Described

March 30, 1979